Interobserver agreement in the nuclear grading of primary pulmonary adenocarcinoma

Journal of Thoracic Oncology

Volumn 8, Issue 6, 2013, Pages 736-743

  Nakazato, Yoshimasa ^a,b   Maeshima, Akiko Miyagi ^c   Ishikawa, Yuichi ^d   Yatabe, Yasushi ^e   Fukuoka, Junya ^f   Yokose, Tomoyuki ^g   Tomita, Yasuhiko ^h   Minami, Yuko ⁱ   Asamura, Hisao ^c   Tachibana, Keisei ^j   Goya, Tomoyuki ^j   Noguchi, Masayuki ⁱ  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b GUNMA PREFECTURAL CANCER CENTER   (Japan)

^c NATIONAL CANCER CENTER HOSPITAL   (Japan)

^d CANCER INSTITUTE HOSPITAL   (Japan)

^e AICHI CANCER CENTER HOSPITAL   (Japan)

^f TOYAMA UNIVERSITY HOSPITAL   (Japan)

^g KANAGAWA CANCER CENTER   (Japan)

^h OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

ⁱ UNIVERSITY OF TSUKUBA   (Japan)

^j KYORIN UNIVERSITY   (Japan)

more..

Author keywords

Extent of lepidic area; Histological classification; Interobserver agreement; Nuclear grading; Pulmonary adenocarcinoma

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CANCER GROWTH; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; DISEASE FREE SURVIVAL; FOLLOW UP; HUMAN; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; NUCLEAR GRADING; PRIORITY JOURNAL; SURVIVAL RATE;

EID: 84879488666     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e318288dbd8     Document Type: Article

References (18)

1. Goya T, Asamura H, Yoshimura H, et al.; Japanese Joint Committee of Lung Cancer Registry. Prognosis of 6644 resected non-small cell lung cancers in Japan: a Japanese lung cancer registry study. Lung Cancer 2005;50:227-234. (Pubitemid 41427898)
2. Mitsudomi T, Kosaka T, Endoh H, et al. Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non-small-cell lung cancer with postoperative recurrence. J Clin Oncol 2005;23:2513-2520. (Pubitemid 47050841)
3. Maeshima AM, Tochigi N, Yoshida A, Asamura H, Tsuta K, Tsuda H. Histological scoring for small lung adenocarcinomas 2 cm or less in diameter: a reliable prognostic indicator. J Thorac Oncol 2010;5:333-339.
4. Nakazato Y, Minami Y, Kobayashi H, et al. Nuclear grading of primary pulmonary adenocarcinomas: correlation between nuclear size and prognosis. Cancer 2010;116:2011-2019.
5. Davis BW, Gelber RD, Goldhirsch A, et al. Prognostic significance of tumor grade in clinical trials of adjuvant therapy for breast cancer with axillary lymph node metastasis. Cancer 1986;58:2662-2670. (Pubitemid 17232925)
6. Henson DE. End points and significance of reproducibility in pathology. Arch Pathol Lab Med 1989;113:830-831. (Pubitemid 19206379)
7. Travis WD, Brambilla E, Noguchi M, et al. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011;6:244-285.
8. Noguchi M, Morikawa A, Kawasaki M, Matsuno Y, Yamada T, Hirohashi S, et al. Small adenocarcinoma of the lung - histologic characteristics and prognosis. Cancer 1995;75(12):2844-52.
9. Minami Y, Matsuno Y, Iijima T, et al. Prognostication of small-sized primary pulmonary adenocarcinomas by histopathological and karyometric analysis. Lung Cancer 2005;48:339-348. (Pubitemid 40693619)
10. Anami Y, Iijima T, Suzuki K, et al. Bronchioloalveolar carcinoma (lepidic growth) component is a more useful prognostic factor than lymph node metastasis. J Thorac Oncol 2009;4:951-958.
11. Yokose T, Suzuki K, Nagai K, Nishiwaki Y, Sasaki S, Ochiai A. Favorable and unfavorable morphological prognostic factors in peripheral adenocarcinoma of the lung 3 cm or less in diameter. Lung Cancer 2000;29:179-188.
12. Yoshizawa A, Motoi N, Riely GJ, et al. Impact of proposed IASLC/ATS/ ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases. Mod Pathol 2011;24:653-664.
13. Eleiss J.L. Statistical methods for rates and proportions. New York, John Wiley and Sons. 1981; 212-36.
14. Cagle PT, Langston C, Fraire AE, Roggli VL, Greenberg SD. Absence of correlation between nuclear morphometry and survival in stage I nonsmall cell lung carcinoma. Cancer 1992;69:2454-2457.
15. Petersen I, Kotb WF, Friedrich KH, Schlüns K, Böcking A, Dietel M. Core classification of lung cancer: correlating nuclear size and mitoses with ploidy and clinicopathological parameters. Lung Cancer 2009;65:312-318.
16. Kadota K, Suzuki K, Kachala SS, et al. A grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma. Mod Pathol 2012;25:1117-1127.
17. Morishita Y, Fukasawa M, Takeuchi M, Inadome Y, Matsuno Y, Noguchi M. Small-sized adenocarcinoma of the lung. Cytologic characteristics and clinical behavior. Cancer 2001;93:124-131. (Pubitemid 32322167)
18. Sigel CS, Rudomina DE, Sima CS, et al. Predicting pulmonary adenocarcinoma outcome based on a cytology grading system. Cancer Cytopathol 2012;120:35-43.